Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 18.73B P/E - EPS this Y 8.70% Ern Qtrly Grth 507.60%
Income 206.3M Forward P/E 126.76 EPS next Y 26.40% 50D Avg Chg -5.00%
Sales 1.7B PEG 3.09 EPS past 5Y 75.15% 200D Avg Chg -8.00%
Dividend N/A Price/Book 37.25 EPS next 5Y 18.10% 52W High Chg -20.00%
Recommedations 1.80 Quick Ratio 2.36 Shares Outstanding 70.02M 52W Low Chg 29.00%
Insider Own 0.31% ROA 6.09% Shares Float 69.53M Beta 1.00
Inst Own 103.52% ROE 34.13% Shares Shorted/Prior 3.12M/2.68M Price 268.74
Gross Margin 67.67% Profit Margin 12.16% Avg. Volume 569,746 Target Price 236.83
Oper. Margin 26.07% Earnings Date May 9 Volume 386,056 Change -0.81%
About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation News
04/24/24 Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
04/19/24 5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
04/18/24 Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
04/17/24 Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
04/17/24 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
04/15/24 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
04/15/24 7 Stable Stocks for 50% Returns by Early 2025
04/15/24 Earnings growth outpaced the impressive 16% CAGR delivered to Insulet (NASDAQ:PODD) shareholders over the last five years
04/12/24 Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
04/10/24 Insulet (PODD) Stock Moves -0.34%: What You Should Know
04/10/24 Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands
04/03/24 Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
04/02/24 Here's Why Insulet (PODD) is a Strong Growth Stock
04/02/24 5 Medical Product Stocks to Buy Amid Industry Challenges
03/28/24 Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?
03/28/24 Investors Will Want Insulet's (NASDAQ:PODD) Growth In ROCE To Persist
09:28 AM The Zacks Analyst Blog Highlights Twilio, Zscaler, NextEra Energy, and American Water Works
03/22/24 5 Stocks to Buy on the Dip to Gain From the Wall Street Rally
03/21/24 Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside
03/21/24 3 Strong Stocks Down at Least 30% to Buy Now
PODD Chatroom

User Image crabbypatty31 Posted - 1 day ago

@NorthstarT1D @CH_Expat Yep, Dexcom + Omnipod are a marvelous team! Hoping $PODD finally moves up. It's been awhile...Dexcom has been a beast. They really have the CGM market cornered, so why do I never buy their stock???;))

User Image CH_Expat Posted - 1 day ago

$PODD Tandem with another random 10% plus day.

User Image QuiverQuant Posted - 4 days ago

CONGRESSIONAL TRADING: Senator Smith, Tina disclosed a sale (partial) of $50,001 - $100,000 of $PODD on 2024-04-19.

User Image crabbypatty31 Posted - 5 days ago

$PODD $163 seems to be holding as support. Dipped a tad below but not much. Sad that so many meme/junk stocks are booming and this is just sitting there percolating...

User Image BriOnH Posted - 5 days ago

@NorthstarT1D @Xxs @Gv32832 @NorthstarT1D @Gv32832 @Xxs the crux of the matter is he is right that type 2 will generate more revenue, because there is a bigger population, and glps go to an even bigger population beyond diabetes. Also, bright enough to semi-understand impacts on type 1, which is more than a lot that rudely blast glps in here. Over time glps prob are a good bet. However, what we see as type 1s, he just can’t really understand the $PODD investment because he doesn’t understand the burden of treating type 1. I invest in podd and Dxcm because I know first hand what it does for me in the treatment of type 1, what it does for other type 1s on it, and most importantly what it will do for the huge population of type 1s not yet on it, and how much better their lives will be once they get on it.

User Image NorthstarT1D Posted - 5 days ago

$PODD traders playing games with Podd every day, sad to see

User Image Xxs Posted - 1 week ago

$PODD What growth potential does this company have? T1D is on the up and up, but it’s not as lucrative to treat as T2D. GLP-1 can be used to treat both, moreso T2D - are they developing pumps or equipment to administer GLP-1? How are they keeping up with the growing diabetic population? My initial review of patient testimony is that this company sucks at getting insurance companies to approve their product

User Image Xxs Posted - 1 week ago

$PODD what caused the big drop in 2023?

User Image NorthstarT1D Posted - 1 week ago

$PODD wtf is this. Lilly releases a study about sleep apnea and diabetes stocks are losing almost as much as sleep apnea device makers. Seems the moment Lilly does anything people start selling Podd? Clear buy for me

User Image NorthstarT1D Posted - 1 week ago

$PODD quite some movement in the premarket. Maybe because of the Lilly news? Doesn't seem to apply to Podd this time though

User Image NorthstarT1D Posted - 1 week ago

$PODD crushed again on very low volume. Time to load up

User Image StockInvest_us Posted - 1 week ago

Signal alert: $PODD - PivotPoint bottom https://stockinvest.us/l/NOvRRNt326

User Image NorthstarT1D Posted - 1 week ago

$PODD here we go again, bought some calls at the lows yesterday before the rebound, think I'll do that again today

User Image John_Wick1234 Posted - 1 week ago

$PODD Nice Double Bottom

User Image crabbypatty31 Posted - 1 week ago

$AAPL Noticing a pattern amongst these stocks $AAPL, $TSLA,$PODD, etc. Very respected financial analysts all recommending shorting/selling these stocks at their recent low low lows only to have all of them surge. Think they are buying what retail is selling at the bottom. Any thoughts?

User Image Super7Billiards Posted - 1 week ago

$PODD is this gonna rally when they come out with iPhone app for omnipod 5? Just don’t like that I have to carry separate device.

User Image ShitPosterExtraordinar Posted - 1 week ago

@NYCBio huge losses over the last year getting mobi pump to market, topped off with manjaro craze sell off that was somehow going to cure T1D. That's when I bought. Now we wait to see if they can become profitable this year like they said in last ER. IMO the mobi pump is the Kmart of insulin pumps, and won't see a huge demand like $PODD but if they stop losing money then they should be $40 to $80 stock price. $TNMD new all in one pump that won't be out for a few years is more exciting than the mobi pump. That could take market share but it takes years for pump business cycles to complete. Everyone who got the first tandem pumps with algo's 4 yrs ago should be eligible for new pumps now and that is why TNDM wanted the mobi pump ready this year. It should keep them from losing market share but was it worth the money, we will find out.

User Image NorthstarT1D Posted - 1 week ago

$PODD pfff again 😣

User Image CilantroTrading Posted - 2 weeks ago

$PODD $182 tomorrow? Looks like it.

User Image MaverikIT Posted - 2 weeks ago

@IsabellaDC @net0trader @DonCorleone77 @Cash4freedom @Im_not_Mr_Lebowski @RonIsWrong @Wigglyick $PODD

User Image CilantroTrading Posted - 2 weeks ago

$PODD Finally starting to run. Low volume though. The limit sell orders I had set a while ago in the 177s got filled. I hope it continues to run from here.

User Image NorthstarT1D Posted - 2 weeks ago

$PODD this stock seems cursed 😣

User Image NorthstarT1D Posted - 2 weeks ago

$PODD 10k shares can make this move 1% atm. Just saying...

User Image CH_Expat Posted - 3 weeks ago

$PHAT $URGN $PODD are my holdings at the moment. Not much to cheer about, but this is when you buy.

User Image CH_Expat Posted - 3 weeks ago

$PODD Tandem outperforms PODD every day - for a reason I do not understand. Expect a move here soon in any direction.

User Image Stock_Titan Posted - 3 weeks ago

$PODD Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 https://www.stocktitan.net/news/PODD/insulet-to-announce-first-quarter-2024-financial-results-on-may-9-3ttx8xevlbvn.html

User Image KingTraderz Posted - 3 weeks ago

$PODD added more. Every month little by little on this.

User Image NorthstarT1D Posted - 3 weeks ago

$PODD how many times is this going to test the support still? Again sliding on low volume, perfect buy at these levels

User Image Onthemoney1214 Posted - 3 weeks ago

$PODD As a user, its frustrating that they cannot get Dexcom G7 integration and iPhone app usage into the market faster. Both are approved by the FDA. WTF!

User Image CH_Expat Posted - 3 weeks ago

$PODD Added despite my original plans again at 163 USD.

Analyst Ratings
Barclays Equal-Weight Feb 26, 24
Piper Sandler Overweight Feb 23, 24
JP Morgan Overweight Feb 23, 24
Stifel Hold Feb 5, 24
Baird Outperform Dec 21, 23
Morgan Stanley Overweight Dec 4, 23
Piper Sandler Overweight Nov 3, 23
JP Morgan Overweight Oct 17, 23
Leerink Partners Outperform Oct 16, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Petrovic Shacey Director Director Nov 13 Sell 164.79 35,000 5,767,650 2,567 11/14/23
Petrovic Shacey Director Director Nov 13 Option 83.31 20,000 1,666,200 22,567 11/14/23
Singh Prem SVP, Global Operatio.. SVP, Global Operations Sep 19 Buy 168.92 1 169 4,032 09/21/23
Petrovic Shacey Advisor Advisor Feb 28 Sell 276.63 15,000 4,149,450 58,205 03/01/23
Petrovic Shacey Director Director Dec 15 Option 74.5 1,094 81,503 14,789 12/19/22
Petrovic Shacey President and CEO President and CEO Apr 02 Option 30.58 15,000 458,700 56,589 04/02/21